Extensive peptide capacity JPT Peptide Technologies operates a large peptide synthesis facility with the ability to produce over one million peptides per year, indicating a strong potential for high-volume custom orders and scalable partnerships.

Modified and specialized peptides The company offers a wide range of peptide modifications including macrocyclic peptides, PTMs, labeled, biotinylated, radioligands, isotope labeling, and more, presenting opportunities to upsell services for advanced research, diagnostics, and therapeutics development.

PepMix and pools With ready-made PepMix peptide pools and extensive stock (over 500 PepMixes) for immune monitoring and T-cell stimulation, there is a clear path to collaborate with labs and contract researchers needing ready-to-use immune assays and controls.

Clinical and immuno focus Clinical grade peptides approved for immunotherapy, vaccine development, and clinical proteomics suggest opportunities to partner with pharma and biotech companies pursuing translational and clinical research programs.

Global, ethical positioning Made in Germany with global support and adherence to ethical, environmental, and health standards positions JPT as a reliable supplier for regulated environments, appealing to multinational institutions and contract research organizations seeking compliant peptide supply.